Zavodnick Todd Erik 4
4 · Revance Therapeutics, Inc. · Filed Feb 9, 2018
Insider Transaction Report
Form 4
Zavodnick Todd Erik
CCO & President,
Transactions
- Award
Common Stock
[F1]2018-02-08+8,500→ 103,500 total - Award
Employee Stock Option (Right to Buy)
[F2]2018-02-08+48,750→ 48,750 totalExercise: $29.15Exp: 2028-02-07→ Common Stock (48,750 underlying)
Footnotes (2)
- [F1]The shares subject to the Restricted Stock award shall vest in three (3) equal annual installments beginning from March 15, 2018, subject to Mr. Zavodnick's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan(the "Plan")) on each vesting date.
- [F2]The shares subject to the stock option shall vest in forty-eight (48) equal monthly installments beginning from February 8, 2018, subject to Mr. Zavodnick's Continuous Service (as defined in the Plan) on each vesting date.
Signature
/s/ Gordon Ho, Attorney-in-Fact|2018-02-09